Pancreatic Cancer Research

ResearcherKeio UniversityActive in the last 2 years

Koichi Aiura

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5005395606. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 12

  1. Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02): A Phase 2 Clinical Tria… Co-author DOI 10.1245/s10434-025-17661-7↗
  2. Adjuvant 5-fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer. Co-author DOI 10.1002/cam4.7459↗
  3. Efficacy and safety of neoadjuvant S-1-based chemoradiotherapy in resectable and borderline-resectable pancreatic cancer: a long-term follow-up study. Co-author DOI 10.1186/s12957-024-03609-w↗
  4. Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline rese… Co-author DOI 10.1186/s12957-019-1687-4↗
  5. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study. Co-author DOI 10.1002/cam4.1178↗
  6. Corrigendum to "Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative rese… Co-author DOI 10.1016/j.pan.2016.12.014↗
  7. Mass-forming type 1 autoimmune pancreatitis mimicking pancreatic cancer. First author DOI 10.1111/1751-2980.12316↗
  8. Successful resolution of a hemorrhagic pancreatic pseudocyst ruptured into the stomach complicating obstructive pancreatitis due to pancreatic cancer: a case r… First author DOI 10.1186/s12957-016-0812-x↗
  9. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Co-author DOI 10.1111/cas.12621↗
  10. Two Cases of Pathological Complete Response to Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer. Co-author DOI 10.2302/kjm.2014-0014-cr↗
  11. Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer. First author DOI 10.1007/s10585-012-9544-7↗
  12. Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells. Co-author DOI 10.1111/cas.12059↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Minoru Kitago · 7 shared papers, 2015–2025 · strength 0.82
  2. Yuta Abe · 6 shared papers, 2015–2025 · strength 0.78
  3. Yutaka Nakano · 5 shared papers, 2017–2025 · strength 0.74
  4. Yutaka Endo · 4 shared papers, 2019–2025 · strength 0.67
  5. Yuko Kitagawa · 8 shared papers, 2013–2025 · strength 0.61
  6. Junichi Matsui · 3 shared papers, 2017–2025 · strength 0.49
  7. Yutaka Takigawa · 2 shared papers, 2024–2025 · strength 0.40
  8. Yuko Kitagawa · 2 shared papers, 2024 · strength 0.37
  9. Sojun Hoshimoto · 3 shared papers, 2016–2025 · strength 0.36
  10. Yohei Masugi · 4 shared papers, 2013–2024 · strength 0.35
  11. Shutaro Hori · 2 shared papers, 2019–2024 · strength 0.27
  12. Yosuke Uematsu · 1 shared paper, 2025 · strength 0.22
  13. Gaku Shimane · 1 shared paper, 2024 · strength 0.19
  14. Masayuki Tanaka · 1 shared paper, 2024 · strength 0.19
  15. Minoru Tanabe · 1 shared paper, 2024 · strength 0.18
  16. Hitoshi Sugiura · 2 shared papers, 2016 · strength 0.15
  17. Shigeyuki Kawachi · 2 shared papers, 2013–2015 · strength 0.07
  18. Michiie Sakamoto · 2 shared papers, 2013–2015 · strength 0.07
  19. Hiromasa Takaishi · 2 shared papers, 2013–2015 · strength 0.07
  20. Yasuo Hamamoto · 2 shared papers, 2013–2015 · strength 0.07
  21. Motomu Tanaka · 1 shared paper, 2016 · strength 0.07
  22. Yoko Fujii‐Nishimura · 1 shared paper, 2015 · strength 0.04
  23. Makoto Sunamura · 1 shared paper, 2015 · strength 0.04
  24. Masato Okamoto · 1 shared paper, 2015 · strength 0.04
  25. Shuhei Mayanagi · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.